BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 3499922)

  • 1. PMN C5a-receptor down regulation is not involved in recovery from C5a-induced neutropenia.
    Gardinali M; Hugli TE; Ward DM; Agostoni A
    ASAIO Trans; 1987; 33(3):482-8. PubMed ID: 3499922
    [No Abstract]   [Full Text] [Related]  

  • 2. C5a receptor modulation on neutrophils and monocytes from chronic hemodialysis and peritoneal dialysis patients.
    Lewis SL; Van Epps DE; Chenoweth DE
    Clin Nephrol; 1986 Jul; 26(1):37-44. PubMed ID: 3488153
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of complement activation by hemodialysis membranes.
    Cheung AK; Henderson LW
    Am J Nephrol; 1986; 6(2):81-91. PubMed ID: 3518458
    [No Abstract]   [Full Text] [Related]  

  • 4. Anaphylatoxin C5a generation and dialysis-induced leukopenia with different hemodialyzer membranes.
    Aljama P; Martín-Malo A; Castillo D; Velasco F; Torres A; Pérez R; Castro M
    Blood Purif; 1986; 4(1-3):88-92. PubMed ID: 3730166
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute changes in C3a and C5a in an anaphylactoid reaction in hemodialysis patients.
    Suzuki Y; Uchida J; Tsuji H; Kuzuhara K; Hara S; Nihei H; Ogura Y; Otsubo O; Mimura N
    Tohoku J Exp Med; 1987 May; 152(1):35-45. PubMed ID: 3497472
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dialysis leukopenia, hypoxemia, and anaphylatoxin formation: effect of membrane, bath, and citrate anticoagulation.
    Wiegmann TB; MacDougall ML; Diederich DA
    Am J Kidney Dis; 1988 May; 11(5):418-24. PubMed ID: 3259402
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The properties of human C5a anaphylatoxin. The significance of C5a formation during hemodialysis.
    Chenoweth DE
    Contrib Nephrol; 1987; 59():51-71. PubMed ID: 3327650
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Leukocyte C5a receptor modulation during hemodialysis.
    Lewis SL; Van Epps DE; Chenoweth DE
    Kidney Int; 1987 Jan; 31(1):112-20. PubMed ID: 2951551
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cellulose membranes--time for a change?
    Henderson LW; Chenoweth DE
    Contrib Nephrol; 1985; 44():112-26. PubMed ID: 3872769
    [No Abstract]   [Full Text] [Related]  

  • 10. Role of complements C3 and C5 in the phagocytosis of liposomes by human neutrophils.
    Scieszka JF; Maggiora LL; Wright SD; Cho MJ
    Pharm Res; 1991 Jan; 8(1):65-9. PubMed ID: 1826557
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of complement activation during extracorporeal circulation by measurement of complement split C3d.
    Knudsen F
    Blood Purif; 1987; 5(2-3):162-7. PubMed ID: 3497646
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure and function of human C5a anaphylatoxin. Selective modification of tyrosine 23 alters biological activity but not antigenicity.
    Johnson RJ; Chenoweth DE
    J Biol Chem; 1985 Aug; 260(18):10339-45. PubMed ID: 2410424
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Complement as a mediator of granulocyte adherence and margination: studies based on the acute neutropenia of filtration leukapheresis.
    Fehr J
    Prog Clin Biol Res; 1977; 13():243-58. PubMed ID: 400757
    [No Abstract]   [Full Text] [Related]  

  • 14. C5a receptor.
    Huey R; Hugli TE
    Methods Enzymol; 1987; 150():615-27. PubMed ID: 3431434
    [No Abstract]   [Full Text] [Related]  

  • 15. Biocompatibility of a new polycarbonate dialysis membrane.
    Knudsen F; Nielsen AH; Pedersen JO; Grunnet N; Jersild C
    Blood Purif; 1986; 4(1-3):142-6. PubMed ID: 2942156
    [TBL] [Abstract][Full Text] [Related]  

  • 16. C3a and C5a receptor antagonists ameliorate endothelial-myofibroblast transition via the Wnt/β-catenin signaling pathway in diabetic kidney disease.
    Li L; Chen L; Zang J; Tang X; Liu Y; Zhang J; Bai L; Yin Q; Lu Y; Cheng J; Fu P; Liu F
    Metabolism; 2015 May; 64(5):597-610. PubMed ID: 25682062
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microvascular effects of anaphylatoxins C3a and C5a.
    Björk J; Hugli TE; Smedegård G
    J Immunol; 1985 Feb; 134(2):1115-9. PubMed ID: 3871207
    [TBL] [Abstract][Full Text] [Related]  

  • 18. C5a receptors on neutrophils and monocytes from chronic dialysis patients.
    Lewis SL
    Adv Exp Med Biol; 1991; 297():167-81. PubMed ID: 1767749
    [No Abstract]   [Full Text] [Related]  

  • 19. Plasma clearance of the human C5a anaphylatoxin by binding to leucocyte C5a receptors.
    Oppermann M; Götze O
    Immunology; 1994 Aug; 82(4):516-21. PubMed ID: 7835913
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Cigarette smoking and lung metabolism--effects of cigarette smoking on plasma levels of complement C3a and C5a in rabbits].
    Kihira Y; Kuratomi Y; Matsuoka R; Kitamura S
    Nihon Kyobu Shikkan Gakkai Zasshi; 1987 Jun; 25(6):643-8. PubMed ID: 3500346
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.